Could Falling Hepatitis B Vaccine Rates Reverse Decades of Progress? скачать в хорошем качестве

Could Falling Hepatitis B Vaccine Rates Reverse Decades of Progress?

For decades, universal newborn vaccination against hepatitis B has been a cornerstone of pediatric preventive care in the United States, widely regarded not only as protection against viral infection, but as a powerful tool in preventing chronic liver disease and liver cancer later in life. New data published in JAMA suggest that uptake of the birth dose may be slipping at a pivotal moment. Against a backdrop of evolving vaccine policy and shifting public discourse around immunization, these findings raise urgent questions about whether progress toward hepatitis B elimination could be at risk. In discussing the findings from his research, Joshua Rothman, MD, MS, a clinical assistant professor in the department of pediatrics and Medical Director of Informatics Academic Pediatrics at the University of California San Diego, emphasized the critical importance of hepatitis B vaccination in infancy. Full article: https://www.hcplive.com/view/declinin...